Kenneth Erland Johnson - Senior Vice President, Global Development and Medical Affairs at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Senior Vice President, Global Development and Medical Affairs
Stock Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth Erland Johnson since 11/5/2023

Holdings reported by Kenneth Erland Johnson for Xeris Biopharma Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 373K $918K $2.46 Jan 31, 2024 Direct

Transactions reported by Kenneth Erland Johnson for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.